Ashton Thomas Private Wealth, LLC

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 2019663 SCOTTSDALE, AZ

Position in CPRX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$948,109

+$605,455 QoQ

Shares Held

38,292

+160.8% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Ashton Thomas Private Wealth, LLC holds $8,478,289 across 12 Biotechnology names. CPRX ranks #5 (11.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	33,597	$3,162,149
2	EXEL	Exelixis, Inc.	26,638	$1,142,503
3	VRTX	Vertex Pharmaceuticals Inc / Ma	2,556	$1,141,356
4	HALO	Halozyme Therapeutics, Inc.	15,234	$984,573
5	CPRX	Catalyst Pharmaceuticals, Inc. This page	38,292	$948,109
6	LGND	Ligand Pharmaceuticals Inc	2,194	$438,032
7	ARGX	Argenx SE	284	$207,391
8	NAUT	Nautilus Biotechnology, Inc.	45,000	$174,600

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$948,109	38,292	+160.8%	Shares	Sole	2026-05-11
2025-12-31	$342,654	14,681	+2.2%	Shares	Sole	2026-01-29
2025-09-30	$283,010	14,366	-10.3%	Shares	Sole	2025-11-04
2025-06-30	$347,438	16,011	+23.0%	Shares	Sole	2025-08-01
2025-03-31	$315,589	13,014	+7.4%	Shares	Sole	2025-05-16
2024-12-31	$252,840	12,115	+2.3%	Shares	Sole	2025-02-07
2024-09-30	$235,359	11,839	+0.7%	Shares	Sole	2024-11-05
2024-06-30	$182,084	11,755	+3.0%	Shares	Sole	2024-08-07
2024-03-31	$181,923	11,413	+9.8%	Shares	Sole	2024-04-22
2023-12-31	$174,807	10,399	-1.8%	Shares	Sole	2024-04-22
2023-09-30	$123,785	10,589	+1.8%	Shares	Sole	2024-04-22
2023-06-30	$139,762	10,399	—	Shares	Sole	2024-04-23
No filing history on record for this holder in this stock.